EP3402468 - Bibliographic data
INHIBITEURS DE PI3K P-DELTA 110 POUR UTILISATION DANS L'ADMINISTRATION DE VIRUS POUR TRAITER LE CANCER
| Last update | 21/07/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
Queen Mary University of London Mile End Road
London E1 4NS
Royaume-Uni
|
|---|---|
| (72) Inventors |
Yaohe WANG Molecular Oncology Barts Cancer Institute
Queen Mary University of London
Ground Floor
John Vane Science Centre
London EC1M 6BQ
Royaume-Uni
Mark FERGUSON Molecular Oncology Barts Cancer Institute
Queen Mary University of London
Ground Floor
John Vane Science Centre
London EC1M 6BQ
Royaume-Uni
Nicholas R LEMOINE Molecular Oncology Barts Cancer Institute
Queen Mary University of London
Ground Floor
John Vane Science Centre
London EC1M 6BQ
Royaume-Uni
|
| (74) Agent |
Mail recipient
KILBURN & SRODE LLP Lacon London
84 Theobalds Road
WC1X 8NL
London
Royaume-Uni
|
| (21) Request number | EP17701004.8 |
|---|---|
| (22) Request date | 11/01/2017 |
| (11) Publication number | EP3402468 |
|---|---|
| Publication date | 26/07/2023 |
| (54) Title of the invention | INHIBITEURS DE PI3K P-DELTA 110 POUR UTILISATION DANS L'ADMINISTRATION DE VIRUS POUR TRAITER LE CANCER |
|---|---|
| (51) International classification | A61K 31/00, A61K 35/76 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201662277002 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | Annuity: 10 - Amount: 195 € - Due date 02/02/2026 |
|---|---|
| Last annuity | Annuity: 9 - Payment date 29/01/2025 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 26/07/2023 Constitution de mandataire pour un dossier - Legal date 03/08/2023 Entrée en période de grâce du brevet d'invention - Legal date 01/02/2024 |